Usage of recombinant human bone morphogenetic protein in cervical spine procedures analysis of the marketscan longitudinal database

Journal of Bone and Joint Surgery - American Volume

Volumn 96, Issue 17, 2014, Pages 1409-1416

  Cole, Tyler ^a   Veeravagu, Anand ^a   Jiang, Bowen ^a   Ratliff, John K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; BONE MORPHOGENETIC PROTEIN;

ADULT; ANALGESIA; ARTICLE; CERVICAL SPINE; DRUG COST; DYSPHAGIA; FEMALE; FOLLOW UP; HEMATOMA; HOSPITAL BILLING; HUMAN; ICD-9-CM; INTERVERTEBRAL DISKECTOMY; INTRAOPERATIVE PERIOD; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PATIENT REFERRAL; PATIENT SELECTION; PHYSICIAN; POSTOPERATIVE COMPLICATION; PROPENSITY SCORE; REOPERATION; SEROMA; SPINE SURGERY; TREATMENT DURATION; AGED; COMPARATIVE STUDY; DRUG EFFECT; EVALUATION STUDY; FACTUAL DATABASE; LONGITUDINAL STUDY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; SPINE DISEASE; SPINE FUSION; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; BONE MORPHOGENETIC PROTEINS; CERVICAL VERTEBRAE; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; DISKECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; ROC CURVE; SPINAL DISEASES; SPINAL FUSION; TREATMENT OUTCOME;

EID: 84907197282     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.M.01016     Document Type: Article

References (41)

1. Burkus JK, Sandhu HS, Gornet MF. Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft. Spine (Phila Pa 1976). 2006 Apr 1;31(7):775-81.
2. Carlisle E, Fischgrund JS. Bone morphogenetic proteins for spinal fusion. Spine J. 2005 Nov-Dec;5(6)(Suppl):240S-9S.
3. Boakye M, Mummaneni PV, Garrett M, Rodts G, Haid R. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg Spine. 2005 May;2(5):521-5.
4. Burkus JK. Bone morphogenetic proteins in anterior lumbar interbody fusion: old techniques and new technologies. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine. 2004 Oct;1(3):254-60.
5. Burkus JK, Heim SE, Gornet MF, Zdeblick TA. The effectiveness of rhBMP-2 in replacing autograft: an integrated analysis of three human spine studies. Orthopedics. 2004 Jul;27(7):723-8.
6. Dawson E, Bae HW, Burkus JK, Stambough JL, Glassman SD. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J Bone Joint Surg Am. 2009 Jul;91(7):1604-13.
7. Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine (Phila Pa 1976). 2002 Dec 1;27(23):2662-73.
8. Boden SD, Zdeblick TA, Sandhu HS, Heim SE. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine (Phila Pa 1976). 2000 Feb 1;25(3):376-81.
9. Dimar JR 2nd, Glassman SD, Burkus JK, Pryor PW, Hardacker JW, Carreon LY. Reply to "A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned". Spine J. 2011 Nov;11(11):1082-3; author reply 1083-6. Epub 2011 Nov 11.
10. Helgeson MD, Lehman RA Jr, Patzkowski JC, Dmitriev AE, Rosner MK, Mack AW. Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion. Spine J. 2011 Jun;11(6):507-10.
11. Mirza SK. Folly of FDA-approval studies for bone morphogenetic protein. Spine J. 2011 Jun;11(6):495-9.
12. Spengler DM. Resetting standards for sponsored research: do conflicts influence results? Spine J. 2011 Jun;11(6):492-4.
13. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011 Jun;11(6):471-91.
14. Kang JD. Another complication associated with rhBMP-2? Spine J. 2011 Jun;11(6):517-9. Epub 2011 May 25.
15. Glassman SD, Gum JL, Crawford CH 3rd, Shields CB, Carreon LY. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear. Spine J. 2011 Jun;11(6):522-6. Epub 2010 Jul 02.
16. Carragee EJ, Baker RM, Benzel EC, Bigos SJ, Cheng I, Corbin TP, Deyo RA, Hurwitz EL, Jarvik JG, Kang JD, Lurie JD, Mroz TE, Oner FC, Peul WC, Rainville J, Ratliff JK, Rihn JA, Rothman DJ, Schoene ML, Spengler DM, Weiner BK. A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research. Spine J. 2012 Oct;12(10):877-80.
17. Even J, Eskander M, Kang J. Bone morphogenetic protein in spine surgery: current and future uses. J Am Acad Orthop Surg. 2012 Sep;20(9):547-52.
18. Lu DC, Tumialán LM, Chou D. Multilevel anterior cervical discectomy and fusion with and without rhBMP-2: a comparison of dysphagia rates and outcomes in 150 patients. J Neurosurg Spine. 2013 Jan;18(1):43-9. Epub 2012 Nov 16.
19. Thawani JP, Wang AC, Than KD, Lin CY, La Marca F, Park P. Bone morphogenetic proteins and cancer: review of the literature. Neurosurgery. 2010 Feb;66(2):233-46; discussion 246.
20. Tumialán LM, Pan J, Rodts GE, Mummaneni PV. The safety and efficacy of anterior cervical discectomy and fusion with polyetheretherketone spacer and recombinant human bone morphogenetic protein-2: a review of 200 patients. J Neurosurg Spine. 2008 Jun;8(6):529-35.
21. Perri B, Cooper M, Lauryssen C, Anand N. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J. 2007 Mar-Apr;7(2):235-9. Epub 2006 Nov 20.
22. Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976). 2006 Nov 15;31(24):2813-9.
23. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976). 2006 Mar 1;31(5):542-7.
24. Schultz DG. FDA public health notification: life-threatening complications associated with recombinant human bone morphogenetic protein in cervical spine fusion. 2008. http://www.fda.gov/medicaldevices/safety/alertsandnotices/publichealthnotifications/ucm062000.htm. Accessed 2013 Jul 4.
25. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005 Nov;43(11):1130-9.
26. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 Jun;45(6):613-9.
27. Dimar JR 2nd, Glassman SD, Burkus JK, Pryor PW, Hardacker JW, Carreon LY. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis. J Bone Joint Surg Am. 2009 Jun;91(6):1377-86.
28. Dimar JR, Glassman SD, Burkus KJ, Carreon LY. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine (Phila Pa 1976). 2006 Oct 15;31(22):2534-9; discussion 2540.
29. Baskin DS, Ryan P, Sonntag V, Westmark R, Widmayer MA. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine (Phila Pa 1976). 2003 Jun 15;28(12):1219-24; discussion 1225.
30. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech. 2002 Oct;15(5):337-49.
31. Comer GC, Smith MW, Hurwitz EL, Mitsunaga KA, Kessler R, Carragee EJ. Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study. Spine J. 2012 Oct;12(10):881-90. Epub 2012 Oct 22.
32. Carragee EJ, Mitsunaga KA, Hurwitz EL, Scuderi GJ. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study. Spine J. 2011 Jun;11(6):511-6. Epub 2011 May 25.
33. Rihn JA, Patel R, Makda J, Hong J, Anderson DG, Vaccaro AR, Hilibrand AS, Albert TJ. Complications associated with single-level transforaminal lumbar interbody fusion. Spine J. 2009 Aug;9(8):623-9. Epub 2009 May 30.
34. Dagostino PR, Whitmore RG, Smith GA, Maltenfort MG, Ratliff JK. Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: review of the Nationwide Inpatient Sample from2002 to 2008. Spine J. 2014 Jan;14(1):20-30. Epub 2012 Dec 05.
35. Carragee EJ, Chu G, Rohatgi R, Hurwitz EL, Weiner BK, Yoon ST, Comer G, Kopjar B. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. J Bone Joint Surg Am. 2013 Sep 04;95(17):1537-45.
36. Frenkel MB, Cahill KS, Javahary RJ, Zacur G, Green BA, Levi AD. Fusion rates in multilevel, instrumented anterior cervical fusion for degenerative disease with and without the use of bone morphogenetic protein. J Neurosurg Spine. 2013 Mar;18(3):269-73. Epub 2013 Jan 25.
37. Vaidya R, Carp J, Sethi A, Bartol S, Craig J, Les CM. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J. 2007 Aug;16(8):1257-65. Epub 2007 Mar 27.
38. Cahill KS, Chi JH, Day A, Claus EB. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA. 2009 Jul 1;302(1):58-66.
39. Campbell PG, Yadla S, Malone J, Zussman B, Maltenfort MG, Sharan AD, Harrop JS, Ratliff JK. Early complications related to approach in cervical spine surgery: single-center prospective study. World Neurosurg. 2010 Aug-Sep;74(2-3):363-8.
40. Fineberg SJ, Ahmadinia K, Oglesby M, Patel AA, Singh K. Hospital outcomes and complications of anterior and posterior cervical fusion with bone morphogenetic protein. Spine (Phila Pa 1976). 2013 Jul 1;38(15):1304-9.
41. Buttermann GR. Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion. Spine J. 2008 May-Jun;8(3):426-35. Epub 2007 Mar 07.